nday
CVE-2022-44754

HCL Domino is susceptible to a stack based buffer overflow vulnerability in lasr.dll in Micro Focus KeyView.

HCL Software / Domino

Fecha de divulgación: . nday aún no tiene constancia de una corrección; eso no significa que no exista parche. Ninguna de las cuatro fuentes de PoC la recoge. No figura en el KEV de CISA.

why these tags

nday derives these tags by fixed rules from the facts below; NVD, the CNA and other sources do not assign them. Vocabulary and rules: ~/tags.

buffer overflow / out-of-bounds write
CWE-787, stated by the ADP CISA-ADP, NVD's analysts y NVD, republishing 134c704f-9b21-4f2e-91b3-4a467353bcc0
remote, unauthenticated
AV:N, PR:N, UI:N in CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H (CVSS 3.1) from the CNA HCL
network
AV:N in CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H (CVSS 3.1) from the CNA HCL
no authentication required
PR:N in CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H (CVSS 3.1) from the CNA HCL
no user interaction
UI:N in CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H (CVSS 3.1) from the CNA HCL
HCL Domino / Notes
affected products in the CVE record: HCL Software · DominoCPE names NVD's analysts give as vulnerable: a:hcltech:domino
mail / collaboration
affected products in the CVE record: HCL Software · DominoCPE names NVD's analysts give as vulnerable: a:hcltech:dominothe product type of HCL Domino / Notes in nday's product registry
etapa
DIS
divulgación
cvss
9.8 CRITICAL v3.1

Ciclo de vida

Eje x en UTC; punto = minuto exacto, barra ancha = solo fecha, hueco = desconocida o inferida.
fecha desconocida
DISdivulgada
2022-12-17T03:33Z
PATparcheada
sin registro aún
ANAanalizada
sin registro aún
POCPoC
sin registro aún
ITWexplotada
sin registro aún
KEVen KEV
sin registro aún

Descripción

HCL Domino is susceptible to a stack based buffer overflow vulnerability in lasr.dll in Micro Focus KeyView. This could allow a remote unauthenticated attacker to crash the application or execute arbitrary code via a crafted Lotus Ami Pro file. This is different from the vulnerability described in CVE-2022-44750.  This vulnerability applies to software previously licensed by IBM.

Original text of the CVE record (cvelist), shown as published.

Exploit conditions

What an attack needs, read from the CVSS vector.
Attack vector AV:N
Network: the attacker only needs to reach it over the network
Attack complexity AC:L
Low: no special conditions; the attacker can expect repeatable success
Privileges required PR:N
None: no account or authorization needed
User interaction UI:N
None: no action by anyone other than the attacker

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

CVSS 3.1 vector from the CVE record, scored by the CNA HCL.

Registro de eventos

+DISdivulgación

HCL publicó el registro CVE. CVSS 9.8, severidad crítica.

fuente cvelist · nday , importación masiva · en bruto
{
  "id": 275917,
  "type": "disclosed",
  "source": "cvelist",
  "url": "https://www.cve.org/CVERecord?id=CVE-2022-44754",
  "occurred_at": "2022-12-17T03:33:30.577Z",
  "observed_at": "2026-11-13T05:37:47.986087Z",
  "is_backfill": true,
  "dedupe_key": "",
  "detail": {
    "cvss": {
      "source": "cna",
      "vector": "CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H",
      "version": "3.1",
      "base_score": 9.8,
      "base_severity": "CRITICAL"
    },
    "ssvc": {
      "timestamp": "2025-04-17T15:19:13.073195Z",
      "automatable": "yes",
      "exploitation": "none",
      "technical_impact": "total"
    },
    "state": "PUBLISHED",
    "date_published": "2022-12-17T03:33:30.577Z",
    "assigner_short_name": "HCL"
  }
}

Report an error

report an error or omission

Something on this page wrong or missing? Tell the editors; if they accept it, this page's revision log says so publicly. Upstream data is not changed.

Debate de investigadores

0 investigadores lo mencionaron en los últimos 7 días

Publicaciones en X de investigadores de la lista de nday que mencionan este CVE, tal como se publicaron. nday no las verifica.

nday aún no ha recopilado publicaciones en X de investigadores de su lista sobre este CVE.

Discussion

0 comments

No comments yet.